Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Unique Phenotypic Features of Inflammatory Bowel Disease Linked to Primary Sclerosing Cholangitis

  • By

  • Haruka Okada

  • Shinya Sugimoto

  • Atsuto Kayashima

  • Yohei Mikami

  • Takanori Kanai

  • Nobuhiro Nakamoto

  • March 19, 2026

Share

Objective:

Emphasize the distinctiveness of PSC-IBD.

Key Findings:
  • Add details on implications for management.
Interpretation:

Strengthen the link to clinical practice.

Limitations:
  • Mention variability in clinical presentation.
Conclusion:

Reiterate the importance of tailored management strategies.

Original Source(s)

Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease

  • by Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto

  • March 19, 2026

Related Content

Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan

Five-Year Outcomes and Disease Trajectories in Moderate-to-Severe Ulcerative Colitis: A Korean Multicenter Inception Cohort